956434-18-7Relevant academic research and scientific papers
KINASE INHIBITORS AND USES THEREOF
-
Paragraph 0256; 0298, (2018/12/13)
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.
FUSED HETEROCYCLIC COMPOUND AND USE THEREOF
-
Page/Page column 71, (2009/02/10)
The present invention relates to a serotonin 5-HT2C receptor activator containing a compound represented by the formula wherein ring A is a 5- or 6-membered aromatic heterocycle optionally having substituent(s), and ring B is a 7- to 9-membered
